$10.88
+0.28 (+2.64%)
Open$10.75
Previous Close$10.60
Day High$10.96
Day Low$10.66
52W High$11.94
52W Low$4.78
Volume—
Avg Volume1.92M
Market Cap1.85B
P/E Ratio—
EPS$-1.01
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+56.1% upside
Current
$10.88
$10.88
Target
$16.98
$16.98
$13.41
$16.98 avg
$22.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 85.95M | 246.41M | 113.39M |
| Net Income | -549,124,052 | -1,416,891,189 | -30,823,495 |
| Profit Margin | -638.9% | -606.9% | -27.2% |
| EBITDA | -600,460,612 | -1,635,428,845 | -42,153,177 |
| Free Cash Flow | — | — | -22,930,380 |
| Rev Growth | -65.1% | -65.1% | +24.3% |
| Debt/Equity | — | — | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |